ResMed Inc. Gross Profit 2009–2025
ResMed Inc. reported $3.05B of gross profit for fiscal 2025. That was 15.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +77.8%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $3.05B | 59.4% | +15.1% |
| FY 2024 | $2.66B | 56.7% | +12.7% |
| FY 2023 | $2.36B | 55.8% | +16.4% |
| FY 2022 | $2.02B | 56.6% | +10.1% |
| FY 2021 | $1.84B | 57.5% | +7.1% |
| FY 2020 | $1.72B | 58.1% | +15.0% |
| FY 2019 | $1.49B | 57.3% | +11.9% |
| FY 2018 | $1.33B | 57.0% | +11.1% |
| FY 2017 | $1.20B | 58.1% | +12.7% |
| FY 2016 | $1.07B | 58.0% | +5.4% |
| FY 2015 | $1.01B | 60.2% | +2.2% |
| FY 2014 | $989.79M | 63.7% | +5.2% |
| FY 2013 | $940.66M | 62.1% | +14.6% |
| FY 2012 | $820.74M | 60.0% | +10.7% |
| FY 2011 | $741.33M | 59.6% | +13.1% |
| FY 2010 | $655.48M | 60.0% | +18.4% |
| FY 2009 | $553.80M | 60.1% | — |
Source: ResMed Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open RMD 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
ResMed Inc. reported $3.05B of gross profit for fiscal 2025. That was 15.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +77.8%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for ResMed Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeResMed Inc. — frequently asked questions
What is ResMed Inc.'s gross profit?
ResMed Inc. (RMD) reported gross profit of $3.05B for fiscal year 2025, per its SEC filings.
How has ResMed Inc.'s gross profit changed over time?
Between fiscal 2009 and 2025, RMD's gross profit grew at roughly 11.3% per year (compound annual rate), from $553.80M to $3.05B.
Where does this data come from?
Figures are computed from ResMed Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.